Tag: Amgen
Raimondo announces $45M in workforce development for the unemployed
PROVIDENCE – In an effort to break down traditional barriers to hiring, Gov. Gina M. Raimondo announced on Tuesday an investment of $45 million...
Amgen pulls high-price version of Repatha in bid to raise sales
NEW YORK – Amgen Inc. will pull its higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of...
Five Questions With: Carol Malysz
In her role as RI Bio’s executive director, Carol Malysz oversees the group’s coordination with health care organizations, life sciences companies, academic centers and...
Amgen will buy Celgene drug in $13.4B antitrust sale
BOSTON – Amgen Inc. will pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset in order to...
Amgen stock climbs on cancer drug promise
NEW YORK – Shares of Amgen Inc. rose as much as 2.3% in pre-market trading after early results from an experimental therapy showed promise...
JENNIFER LYTLE, 36
40 Under Forty 2019 winner:
JENNIFER LYTLE | 36
QUALITY ASSURANCE MANAGER, AMGEN RHODE ISLAND
What is the best advice you have ever received? Success and failures...
Ocean State starting to see growth in biotech industry
RI BIO, a Providence-based biotechnology trade association, is on a mission to put Rhode Island on the biotech industry’s map. Despite the state having...
Amgen Rhode Island workers reap rewards of ‘Caring’
Best Places to Work 2019 | ENTERPRISE (500-plus employees):
1. Amgen Rhode Island
WITH CAREFUL PLANNING, Amgen Rhode Island is utilizing innovation to get its...
Amgen biomanufacturing plant coming soon, bringing jobs, efficiency
WEST GREENWICH – With the foundation ready, next month Amgen Inc. will begin modular construction of its $165 million next-generation biomanufacturing plant on its...
Amgen Rhode Island finds antidote for exporting obstacles
Amgen Rhode Island
Exporting Excellence, 2019 PBN Manufacturing Awards
While Amgen Inc.’s Rhode Island operation usually ships most of its biologic products to the drug manufacturer’s...